Skip to Main Content


Skip Nav Destination

About DMM

About us

Disease Models & Mechanisms (DMM) is an online (author-pays) Open Access international biomedical research journal. It is published by The Company of Biologists, a not-for-profit publishing organisation dedicated to supporting and inspiring the biological community.

DMM was launched in 2008 with the aim of connecting and promoting communication among disease researchers, a broad scientific community that had traditionally been diffused across many different disease- and organism-specific journals. DMM also aims to promote the development of ideas, projects and collaborations among basic researchers, translational scientists and clinicians to support the growing translational emphasis of basic research.

DMM is edited by expert researchers in the field, with the support of a large international academic Editorial Board; all articles are subject to rigorous single-blind peer review. In addition to primary Research and Resources & Methods articles, DMM publishes commissioned Reviews and ‘At a Glance’ poster articles aimed at synthesising the latest advances in a particular branch of translational research, as well as ‘A Model for Life’ interviews and thought-provoking Editorials. DMM also publishes themed special issues on hot topics within the field. For more information on publishing in DMM, please visit our submission, article types and journal policies pages.

All articles in DMM are published under an Open Access model: the journal’s costs are covered primarily by Article Processing Charges (rather than subscription fees). Therefore, we ask that authors of Research and Resources & Methods articles pay a publication charge of $3750 per article (plus VAT if applicable).

DMM offers advance online posting of accepted author manuscripts on its Accepted manuscripts page. Publication of the final version of record is by a continuous publication model; as soon as an article is ready to be published, it is immediately released online rather than waiting for other articles in the issue to be completed, resulting in faster access to the final version of the article. The full-text version of all articles is deposited in PMC by the publisher for immediate release.

Online ISSN 1754-8411. Print ISSN 1754-8403.

What DMM offers

Journal metrics


DMM is a signatory of the DORA declaration, which makes a number of recommendations for improving the way in which the quality of research output is evaluated. In accordance with the recommendations, DMM uses a number of metrics that together can provide a rich view of the journal's performance. In addition, Altmetric data and usage statistics are available for individual articles.


  • 2022 Impact Factor: 4.3
  • Five-year Impact Factor: 5.1
  • Two-year citation median: 3
  • Eigenfactor score: 0.00806
  • Article Influence Score: 1.73589
  • Immediacy Index: 1.4
DMM - citation distribution graph 2022 
  • h-index: 99
  • Scopus CiteScore: 7.5
  • SJR indicator: 1.489
  • SNIP: 0.979


DMM is abstracted and/or indexed by (amongst others): BIOBASE, CAB abstracts, Cambridge Scientific Abstracts, Current Contents, EMBASE, Clarivate Analytics Web of Science, Medline and Scopus. DMM is a member of OASPA (Open Access Scholarly Publishers Association) and is indexed in the Directory of Open Access Journals (DOAJ).

DMM provides transparency around costs, APC pricing and publishing metrics in line with the Plan S Price and Transparency Framework developed by Information Power. More details can be found on our transparent metrics page.

Supporting our community

DMM aspires to connect and support members of the disease research community, including clinician scientists, basic researchers and trainees. The journal aims to achieve this not only by publishing carefully selected content, but also through other means. For example, DMM supports younger researchers in the community through its Travelling Fellowship program, offering up to £2500 to graduate students and post-doctoral researchers who wish to make collaborative visits to other laboratories. Launched in 2015, DMM also offers Conference Travel Grants of up to £600 to early-career scientists wanting to attend meetings and courses related to the areas of research covered by the journal. The Company of Biologists, the publisher of DMM, sponsors numerous meetings and workshops in the field, including Keystone Symposia, Gordon Conferences and EMBO workshops. DMM itself also sponsors speakers to attend international meetings, provides funds for poster prizes and supports small meetings.

The Company of Biologists is committed to improving equity, diversity and inclusion in all our activities. We believe that diversity – in areas including but not limited to geography, ethnicity, gender and career stage – is essential for a community to thrive. As such, we aim to engage a broad and diverse group of authors, reviewers, editors, staff, readers, grant awardees and meeting participants. Find out more about our EDI activities to date, and our plans moving forward, on our EDI page

DMM online

All DMM content is available online, and is fully browsable and searchable. All DMM papers are published as Open Access articles under the CC-BY licence. All articles are deposited by DMM in PMC for immediate release.

DMM is also a participant of the LOCKSS/CLOCKSS project, an international community initiative through which libraries and publishers work together to preserve their digital content for the long-term.


Focus on biodiversity: The Forest of Biologists

The Forest of Biologists logo

The Forest of Biologists is a living and growing forest that has been created as part of a biodiversity initiative that celebrates author and reviewer contributions to the journals of The Company of Biologists. For every Research Article and Review-type article published in Disease Models & Mechanisms (starting in January 2023), a real tree is planted in new forest and a representation of that tree appears in a virtual forest. In addition to planting new trees, we are also funding the restoration and preservation of ancient woodland and dedicating these trees to our peer reviewers, who help us preserve the integrity of the scientific record. The Forest of Biologists is a symbol of the work of the biologists whose research and expertise fills our journal.

The Company of Biologists has chosen to work with the Woodland Trust, the UK’s largest woodland conservation charity, focusing on the role that trees and woods play in tackling the threats of climate change and nature loss.

Read the Editorial to find out more about The Forest of Biologists.

Back to top


Close Modal

or Create an Account

Close Modal
Close Modal